2019³âµµ ¿¬¼¼¾Ïº´¿ø ºÎÀξϼ¾ÅÍ ½ÉÆ÷Áö¿ò : 2019-10-18±³À°ÀÏÀÚ : 2019-10-18
±³À°Àå¼Ò : ¿¬¼¼¾Ïº´¿ø B3 ¼¾Ï°´ç
±³À°ÁÖÁ¦ :
2019³âµµ ¿¬¼¼¾Ïº´¿ø ºÎÀξϼ¾ÅÍ ½ÉÆ÷Áö¿òÁÖÃÖ±â°ü : ¼¼ºê¶õ½ºº´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : »êºÎÀΰú
´ã´çÀÚ : ¾î°æÁø
¿¬¶ôó : 02-2228-2230
À̸ÞÀÏ :
ob@yuhs.ac ±³À°Á¾·ù : »êºÎÀΰú
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 3 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 10-18 ¼¾Ï°´ç 13:00~14:00 Á¢¼ö ¹× µî·Ï ()
±âŸ 10-18 ¼¾Ï°´ç 14:00~14:05 °³È¸»ç ±è»ó¿î(¿¬¼¼ÀÇ´ë)
±âŸ 10-18 ¼¾Ï°´ç 14:05~14:10 Ãà»ç ±Ý±ââ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10-18 ¼¾Ï°´ç 14:10~14:25 Incorporation of functional imaging in ovarian cancer Á¤´ëö(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10-18 ¼¾Ï°´ç 14:25~14:40 Recent updates of FDG PET-CT in ovarian cancer °¿øÁØ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10-18 ¼¾Ï°´ç 14:40~14:55 The role of immunohistochemistry in Gynecologic Oncology Á¶³²ÈÆ(¿¬¼¼ÀÇ´ë)
Åä·Ð 10-18 ¼¾Ï°´ç 14:55~15:00 Q&A Discussion ()
ÈÞ½Ä 10-18 ¼¾Ï°´ç 15:00~15:10 Coffee break ()
±³À°½Ã°£ 10-18 ¼¾Ï°´ç 15:10~15:30 Tailored surgery for ovarian cancer ¾î°æÁø(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10-18 ¼¾Ï°´ç 15:30~15:50 Clinical application of NGS results with PARPi & IO ÀÌÁ¤À±(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10-18 ¼¾Ï°´ç 15:50~16:10 Future directions of clinical trial in ovarian cancer ±è°Ç¹Î(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10-18 ¼¾Ï°´ç 16:10~16:30 Emerging new paradigm of radiotherapy for ovarian cancer ±è¿ë¹è(¿¬¼¼ÀÇ´ë)
ÈÞ½Ä 10-18 ¼¾Ï°´ç 16:30~16:50 Coffee break ()
±³À°½Ã°£ 10-18 ¼¾Ï°´ç 16:50~17:10 Ovarian cancer case #1 (Application of NGS) °¿øÁØ¿Ü8¸í(¿¬¼¼ÀÇ´ë µî)
±³À°½Ã°£ 10-18 ¼¾Ï°´ç 17:10~17:30 Ovarian cancer case #2 (New clinical trial) °¿øÁØ¿Ü8¸í(¿¬¼¼ÀÇ´ë µî)
±³À°½Ã°£ 10-18 ¼¾Ï°´ç 17:30~17:50 Ovarian cancer case #3 (Radiotherapy in recurrent ovarian cancer) °¿øÁØ¿Ü8¸í(¿¬¼¼ÀÇ´ë µî)
±âŸ 10-18 ¼¾Ï°´ç 17:50~18:00 ¸ÎÀ½¸» ±è»ó¿î(¿¬¼¼ÀÇ´ë)